APLI.TO
Appili Therapeutics Inc
Price:  
0.04 
CAD
Volume:  
142,658.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

APLI.TO WACC - Weighted Average Cost of Capital

The WACC of Appili Therapeutics Inc (APLI.TO) is 9.7%.

The Cost of Equity of Appili Therapeutics Inc (APLI.TO) is 15.15%.
The Cost of Debt of Appili Therapeutics Inc (APLI.TO) is 6.85%.

Range Selected
Cost of equity 12.90% - 17.40% 15.15%
Tax rate 0.10% - 0.30% 0.20%
Cost of debt 6.70% - 7.00% 6.85%
WACC 8.8% - 10.5% 9.7%
WACC

APLI.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 1.92 2.17
Additional risk adjustments 0.0% 0.5%
Cost of equity 12.90% 17.40%
Tax rate 0.10% 0.30%
Debt/Equity ratio 1.93 1.93
Cost of debt 6.70% 7.00%
After-tax WACC 8.8% 10.5%
Selected WACC 9.7%